It is the first ruling in a case challenging “shield laws” intended to protect doctors in states that support abortion rights who send abortion pills to states with bans.
The research could further complicate the polarized politics of abortion because the drug in the study is the key ingredient in a pill used for emergency contraception.
Washington State’s program is the first, but other states are expected to try allowing pharmacists to prescribe the pills to counter growing efforts to curtail abortion access.
But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.